NCT07535112 2026-04-16
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Bayer
Phase 1 Not yet recruiting
Bayer
Novartis
Multitude Therapeutics Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gruppo Oncologico Italia Meridionale
Gruppo Oncologico del Nord-Ovest
Charite University, Berlin, Germany
West China Hospital
Fujian Cancer Hospital
Tang-Du Hospital
Fudan University
Liaoning Cancer Hospital & Institute